On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

ASST Melegnano e della Martesana

InstitutionResearch output, impact & collaborations

ASST Melegnano e della Martesana is a institution indexed in ScholarIQ from OpenAlex.

What is known about ASST Melegnano e della Martesana?

ScholarIQrecord summary

ASST Melegnano e della Martesana is a research organisation in Vizzolo Predabissi, IT. OpenAlex records 1,089 works and 41,936 citations for it. 382 researchers list it as their most recent affiliation.

How many works does ASST Melegnano e della Martesana have?

ScholarIQindexed works

ASST Melegnano e della Martesana has 1,089 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for ASST Melegnano e della Martesana →

How many citations does ASST Melegnano e della Martesana have?

ScholarIQcitation count

ASST Melegnano e della Martesana has 41,936 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for ASST Melegnano e della Martesana →

How many researchers are at ASST Melegnano e della Martesana?

ScholarIQresearcher count

ASST Melegnano e della Martesana has 382 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at ASST Melegnano e della Martesana?

ScholarIQavg h-index

ASST Melegnano e della Martesana has an average h-index of 7 in OpenAlex.

Open the OpenAlex record →

What is the ROR of ASST Melegnano e della Martesana?

ScholarIQror

The ROR for ASST Melegnano e della Martesana is on the source record.

Open the ROR →

What is the OpenAlex record for ASST Melegnano e della Martesana?

ScholarIQopenalex

The OpenAlex for ASST Melegnano e della Martesana is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind ASST Melegnano e della Martesana?

ScholarIQtop researchers by citations

Cesare Massa Saluzzo · Hepatocellular Carcinoma Treatment and Prognosis

19 works333 citations

What are the most-cited papers on ASST Melegnano e della Martesana?

ScholarIQmost cited works

Transarterial Chemoembolization for Hepatocellular Carcinoma with Drug-Eluting Microspheres: Preliminary Results from an Italian Multicentre Study

Maurizio Grosso, C Vignali, Pietro Quaretti, Antonio Nicolini, Fabio Melchiorre, G. Gallarato, Irene Bargellini, P Petruzzi, Cesare Massa Saluzzo, S. Crespi, I Sarti

CardioVascular and Interventional Radiology. 2008124 CitationsOPEN ACCESS

Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for unresectable hepatic tumors.

Guido Poggi, Pietro Quaretti, Claudio Minoia, Giovanni Di Bernardo, M. Regazzi Bonora, Raffaella Gaggeri, A. Ronchi, Cesare Massa Saluzzo, Andrea Azzaretti, Giuseppe Rodolico, Michela Montagna, Alessio Amatu, Cristina Teragni, Ilaria Palumbo, Elena Traverso, Stefano Tonini, Laura Villani, M. Scelsi, Paola Baiardi, Maria Grazia Felisi, Federico Sottotetti, Barbara Tagliaferri, Alberto Riccardi

PubMed. 200950 Citations

A study on maximum skin dose in cerebral embolization procedures.

Loredana D’Ercole, Laura Mantovani, Federico Zappoli Thyrion, M. Bocchiola, Andrea Azzaretti, Federico Di Maria, Cesare Massa Saluzzo, Pietro Quaretti, Giuseppe Rodolico, Paola Scagnelli, L. Andreucci

PubMed. 200749 CitationsOPEN ACCESS

MDCT Anatomic Assessment of Right Inferior Phrenic Artery Origin Related to Potential Supply to Hepatocellular Carcinoma and its Embolization

Antonio Basile, Dimitrios Tsetis, Arturo Montineri, Stefano Puleo, Cesare Massa Saluzzo, Giuseppe Runza, Francesco Coppolino, Giovanni Carlo Ettorre, Maria Teresa Patti

CardioVascular and Interventional Radiology. 200736 Citations

Bethanechol versus antiacids in the treatment of gastroesophageal reflux.

Paul Levi, FláviaPeixoto Caldas Marmo, Cesare Massa Saluzzo, D Dell'Olio, N Ansaldi, Luigi Giuliani, Ornella Guardamagna, M. Mostert, Agustina Ponzone

PubMed. 198524 Citations

How much of the research on ASST Melegnano e della Martesana is open access?

ScholarIQopen access share

27%OPEN ACCESS

Gold

Green

Hybrid

Bronze

Closed

73%